Concepedia

James S. Blachly

JS

Statistics

Publications

78

Citations

5.2K

H-Index

38

Active since

2014

Affiliations

The Ohio State University(Current)

Dana-Farber Cancer Institute

University of Alabama at Birmingham

Emory University

Hofstra University

James S. Blachly is an author at The Ohio State University specializing in oncology, molecular oncology, and medicine.

ORCID

Publications per year

2014–2025

78

Publications

78

Ibrutinib Regimens versus Chemoimmunotherapy in Older Patients with Untreated CLL

Jennifer A. Woyach, Amy S. Ruppert, Nyla A. Heerema et al. · New England Journal of Medicine · 2018 · 952 citations · Full text

, , +10

<i>BTK</i><sup>C481S</sup>-Mediated Resistance to Ibrutinib in Chronic Lymphocytic Leukemia

Jennifer A. Woyach, Amy S. Ruppert, Daphne Guinn et al. · Journal of Clinical Oncology · 2017 · 471 citations

, , +16

Consensus guidelines for the diagnosis and management of patients with classic hairy cell leukemia

Michael R. Grever, Omar Abdel‐Wahab, Leslie A. Andritsos et al. · Blood · 2016 · 289 citations · Full text

, , +10

Expression and prognostic impact of lncRNAs in acute myeloid leukemia

Ramiro Garzon, Stefano Volinia, Dimitrios Papaioannou et al. · Proceedings of the National Academy of Sciences · 2014 · 233 citations

, , +17

Menin Inhibition With Revumenib for <i>KMT2A</i> -Rearranged Relapsed or Refractory Acute Leukemia (AUGMENT-101)

Ghayas C. Issa, Ibrahim Aldoss, Michael J. Thirman et al. · Journal of Clinical Oncology · 2024 · 184 citations · Full text

, , +12

1–5 of 78